Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono‐ and dual‐antiplatelet therapy

ISTH Academy, Paul A. Gurbel, 287580

Cross‐reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH‐AH 01/2010 Study

ISTH Academy, Andreas Tiede, 287581

The (non‐)sense of detecting anti‐cardiolipin and anti‐β2glycoprotein I IgM antibodies in the antiphospholipid syndrome

ISTH Academy, Katrien Devreese, 287582

Use of direct oral anticoagulants in antiphospholipid syndrome: Reply

ISTH Academy, fabretti veronique, 287583

Glycosylation sterically inhibits platelet adhesion to von Willebrand factor without altering intrinsic conformational dynamics

ISTH Academy, Matthew Auton, 287584

What the neighbors say

ISTH Academy, Faculty / Presenter(s), 287590

Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro

ISTH Academy, Chunyan Gao, 287591

A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension

ISTH Academy, Mark Toshner, 287592

Screening pulmonary angiogram and the effect on anticoagulation strategies in severe respiratory failure patients on venovenous extracorporeal membrane oxygenation

ISTH Academy, Emma L. Hartley, 287593

A new WHO reference reagent for activated blood coagulation factor X (FXa), human (15/102)

ISTH Academy, Craig Thelwell, 287594

Inflammaging and platelet hyperreactivity: A new therapeutic target?

ISTH Academy, Paul Harrison, 287595

Role of thrombomodulin expression on hematopoietic stem cells

ISTH Academy, Hartmut Weiler, 287596

Issue Information

ISTH Academy, Faculty / Presenter(s), 287597

The 3.2 Å structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain

ISTH Academy, P. Clint Spiegel, 287598

Sex‐specific differences in chronic thromboembolic pulmonary hypertension. Results from the European CTEPH registry

ISTH Academy, P. Clint Spiegel, 287599

Human endothelial cells size‐select their secretory granules for exocytosis to modulate their functional output

ISTH Academy, Daniel Cutler, 287600

ISTH News and Updates: Join the ISTH Today – Student Membership is Now Free!

ISTH Academy, Faculty / Presenter(s), 287606

Changes

ISTH Academy, Faculty / Presenter(s), 287607

Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)

ISTH Academy, Ralf Pasternack, 287608

Professor Russell F. Doolittle (1931‐2019)

ISTH Academy, Faculty / Presenter(s), 287609

Venous thromboembolism in breast cancer patients receiving cyclin‐dependent kinase inhibitors

ISTH Academy, Alok Khorana, 287610

P2X1 ion channel deficiency causes massive bleeding in inflamed intestine and increases thrombosis

ISTH Academy, Cécile Oury, 287611

Fondaparinux pentasaccharide reduces sepsis coagulopathy and promotes survival in the baboon model of Escherichia coli sepsis

ISTH Academy, Cécile Oury, 287612

Mouse Models of Thrombosis

ISTH Academy, Beatrice Hechler & Brian Cooley, 286712

New insights into cancer's exploitation of platelets

ISTH Academy, Joseph Palumbo, 287041

Engineered microparticles and nanoparticles for fibrinolysis

ISTH Academy, Antonio Formentin, 287042

Does cardiorespiratory fitness really influence venous thromboembolism risk?

ISTH Academy, Setor K. Kunutsor, 287043

A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding

ISTH Academy, Umesh Desai, 287044

Platelet reactivity inhibition following ticagrelor loading dose in patients undergoing percutaneous coronary intervention for acute coronary syndrome

ISTH Academy, Vassili Panagides, 287045

Net‐clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more

ISTH Academy, Vassili Panagides, 287046

A Glanzmann thrombasthenia family associated with a TUBB1‐related macrothrombocytopenia

ISTH Academy, Alan Nurden, 287047

ISTH News and Updates: Join the ISTH Today

ISTH Academy, Faculty / Presenter(s), 287048

Platelet‐type von Willebrand disease: Local disorder of the platelet GPIbα β‐switch drives high‐affinity binding to von Willebrand factor

ISTH Academy, Matthew Auton, 287049

Risk factors for cancer‐associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE‐PACC) study

ISTH Academy, Neil Zakai, 287050

The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex

ISTH Academy, Josefin Ahnstrom, 287051

Toward a better understanding of factor XI activation

ISTH Academy, Jonas Emsley, 287052

An anticoagulant that does not cause bleeding – an abrupt stop on the road to the Holy Grail

ISTH Academy, Joost C.M. Meijers, 287053

What the neighbors say

ISTH Academy, Faculty / Presenter(s), 287054

A single‐domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor

ISTH Academy, Cecile Denis, 287055

Heparin‐induced thrombocytopenia: An international assessment of the quality of laboratory testing

ISTH Academy, Rita Selby, 287056

Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis

ISTH Academy, Jeffrey I. Weitz, 287057

Identification of cysteine thiol‐based linkages in ADAMTS13 in support of a non‐proteolytic regulation of von Willebrand factor

ISTH Academy, Heinrich Vogt, 287058

Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta‐analysis

ISTH Academy, Gary H. Lyman, 287059

Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository

ISTH Academy, Maria Efthymiou, 287060

Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis

ISTH Academy, Gary H. Lyman, 287061

Nomenclature of factor XI and the contact system

ISTH Academy, Alvin Schmaier, 287062

Cardiorespiratory fitness and future risk of venous thromboembolism

ISTH Academy, Line H. Evensen, 287063

Issue Information

ISTH Academy, Faculty / Presenter(s), 287064

Activation of toll‐like receptors 2 and 4 on CD34 cells increases human megakaryo/thrombopoiesis induced by thrombopoietin

ISTH Academy, Mirta Schattner, 287065

Rivaroxaban does not affect growth of human pancreatic tumors in mice

ISTH Academy, Nigel Mackman, 287066

Hydrogen‐deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa

ISTH Academy, Joost C.M. Meijers, 287067

Polyphosphate, Zn and high molecular weight kininogen modulate individual reactions of the contact pathway of blood clotting

ISTH Academy, Tabish Armaan, 287068

Pediatric Thrombosis

ISTH Academy, Char Witmer & Heleen van Ommen, 286681

Cancer Associated Thrombosis

ISTH Academy, Faculty / Presenter(s), 286356

Module 2: Treatment of Cancer-Associated Thrombosis

ISTH Academy, Marc Carrier & Simon Noble, 286355

Module1 : Primary Thromboprophylaxis in Ambulatory Patients with Cancer

ISTH Academy, Alok Khorana & Tzu-Fei Wang, 286354

Pre-Test

ISTH Academy, Faculty / Presenter(s), 286353

Personal Information form - mandatory to receive CME

ISTH Academy, Faculty / Presenter(s), 286352

Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study

ISTH Academy, Marcello Di Nisio, 286267

Corrigendum

ISTH Academy, Faculty / Presenter(s), 286268

Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P‐selectin predict occult cancer after unprovoked venous thromboembolism

ISTH Academy, Fredrik Stangenberg, 286269

Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficiencies

ISTH Academy, Delphine Borgel, 286270

Prevalence of postpartum venous thromboembolism risk factors in an Irish urban obstetric population

ISTH Academy, , 286271

Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients

ISTH Academy, Bhavya Doshi, 286272

Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk

ISTH Academy, , 286273

Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study

ISTH Academy, Borge Nordestgaard, 286274

Quality of life and functional limitations after pulmonary embolism and its prognostic relevance

ISTH Academy, Mareike Lankeit, 286275

What The Neighbors Say

ISTH Academy, Faculty / Presenter(s), 286276

Mechanisms of vascular permeability and remodeling associated with hemarthrosis in factor VIII‐deficient mice

ISTH Academy, Esther J. Cooke, 286277

Thrombin: Coagulation's master regulator of innate immunity

ISTH Academy, Edward Conway, 286278

Transgender patients and the role of the coagulation clinician

ISTH Academy, Mareike Lankeit, 286279

International Society on Thrombosis and Haemostasis core curriculum project: Core competencies in laboratory thrombosis and hemostasis

ISTH Academy, Karen Moffat, 286280

ISTH News and Updates: Join the ISTH Today

ISTH Academy, Faculty / Presenter(s), 286281

Glucose metabolism affects coagulation factors: The NEO study

ISTH Academy, Astrid Van Hylckama Vlieg, 286282

Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC

ISTH Academy, Bernard Tardy, 286283

A Genome Wide Association Study on plasma FV levels identified PLXDC2 as a new modifier of the coagulation process

ISTH Academy, Pierre-Emmanuel Morange, 286284

Ischemic limb necrosis in septic shock: What is the role of high‐dose vasopressor therapy?

ISTH Academy, Mareike Lankeit, 286285

Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation

ISTH Academy, Toshiaki Iba, 286286

Issue Information

ISTH Academy, Faculty / Presenter(s), 286287

The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia

ISTH Academy, Allyson M. Pishko, 286288

Aquagenic pruritus in essential thrombocythemia is associated with a higher risk of thrombosis

ISTH Academy, Christelle Le Gall‐Ianotto, 286289

Defective fibrin deposition and thrombus stability in Bambi mice are mediated by elevated anticoagulant function

ISTH Academy, Isabelle Irene Salles-Crawley, 286290

Temporal map of the pig polytrauma plasma proteome with fluid resuscitation and intravenous vitamin C treatment

ISTH Academy, Ramesh Natarajan, 286291

Purification of silica‐free DNA and characterization of its role in coagulation

ISTH Academy, Paul Kim, 286292

Thrombophilia testing: What can be tested & What should be tested

ISTH Academy, Joost Meijers and Saskia Middeldorp, 273715

Recognizing Excellence in Peer Review

ISTH Academy, Faculty / Presenter(s), 286318

The risk of arterial thromboembolic events after cancer diagnosis

ISTH Academy, Babak B. Navi, 286319

Platelet preparation for function testing in the laboratory and clinic: Historical and practical aspects

ISTH Academy, Christian Gachet, 286320

Hemostatic complications associated with ventricular assist devices

ISTH Academy, Thomas Deloughery, 286321

Blood platelet research in autism spectrum disorders: In search of biomarkers

ISTH Academy, Kathleen Freson, 286322

Corrigendum

ISTH Academy, Faculty / Presenter(s), 286323

Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions

ISTH Academy, Mateo Porres‐Aguilar, 286324

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017

ISTH Academy, Pamela L. Lutsey, 286333

Alternative trafficking of Weibel‐Palade body proteins in CRISPR/Cas9‐engineered von Willebrand factor–deficient blood outgrowth endothelial cells

ISTH Academy, Ruben Bierings, 286334

Corrigendum

ISTH Academy, Faculty / Presenter(s), 286335

Blood platelets: Circulating mirrors of neurons?

ISTH Academy, Ilaria Canobbio, 286336

Post‐thrombotic syndrome in children: Measurement properties of CAPTSure, a new diagnostic tool

ISTH Academy, Maria Laura Avila, 286337

Erratum

ISTH Academy, Faculty / Presenter(s), 286338

Factor XII – What's important but not commonly thought about

ISTH Academy, Alvin Schmaier, 286339

Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study

ISTH Academy, Matthew Wanat, 286340